Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

PACS (PACS) Return on Sales: 2022-2024

Historic Return on Sales for PACS (PACS) over the last 3 years, with FY2024 value amounting to 0.01%.

  • PACS's Return on Sales rose 200.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.01% for FY2024, which is 200.0% down from last year.
  • Per PACS's latest filing, its Return on Sales stood at 0.01% for FY2024, which was down 200.0% from 0.04% recorded in FY2023.
  • Over the past 5 years, PACS's Return on Sales peaked at 0.06% during FY2022, and registered a low of 0.01% during FY2024.
  • For the 3-year period, PACS's Return on Sales averaged around 0.04%, with its median value being 0.04% (2023).
  • As far as peak fluctuations go, PACS's Return on Sales plummeted by -300bps in 2023, and later crashed by -200bps in 2024.
  • PACS's Return on Sales (Annual) stood at 0.06% in 2022, then crashed by -42bps to 0.04% in 2023, then tumbled by -63bps to 0.01% in 2024.
  • Its Return on Sales stands at 0.01% for FY2024, versus 0.04% for FY2023 and 0.06% for FY2022.